Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

31 January 2023: Clinical Research

A Retrospective Study to Evaluate the Association Between the Glasgow Prognostic Score and Atrial Fibrillation, Stroke, and Mortality at 30 Days and at 1 Year After Coronary Artery Bypass Graft Surgery

Esra Dönmez 1ABCDEF* , Sevgi Özcan 1ABCDEF , Bülent Mert 2BCD , Berk Özkaynak 2ABDF , Sevil Tuğrul 1ABC , İrfan Şahin 1ABDEF , Ertuğrul Okuyan 1AEF

DOI: 10.12659/MSM.939283

Med Sci Monit 2023; 29:e939283

Table 4 Comparison of demographic, laboratory, and clinical parameters with respect to stroke development in the 1-year followup period.

VariablesStroke (−) n=686Stroke (+) n=26p
Age60.1±9.763.1±9.40.131
Body mass index (kg/m)27.9±4.527.6±3.90.713
EuroSCORE II1.9±1.23.6±2.2
History of HT, n(%)357 (52.2)14 (53.8)0.862
History of CVA, n(%)14 (2.1)11 (42.3)
History of COPD, n(%)128 (18.7)7 (26.9)0.208
History of DM, n (%)282 (41.2)13 (50)0.370
History of CAD, n(%)181 (26.6)8 (30.8)0.636
History of carotid artery disease, n (%)45 (5.2)24 (92.3)
Preoperative treatment, n (%)
 Statins352 (51.4)15 (57.7)0.482
 β-blockers216 (32.1)10 (4)0.407
 ACEI/ARB331 (48.7)16 (64)0.132
Preoperative hemoglobin (g/dl)12.4±1.812.1±1.60.360
Preoperative hematocrit (%)39.2±4.837.5±5.70.082
Ejection fraction, (%)50.9±8.749.5±9.50.423
Glasgow prognostic score, n (%)
GPS=0466 (68.1)6 (23.1)
GPS≥1219 (31.9)20 (76.9)
1-year cardiovascular mortality, n (%)59 (8.6)17 (65.4)
POAF developed patients, n (%)98 (14.3)23 (88.5)
Intensive Care Unit stay (days)3.6±2.66.3±5.3
In-hospital stay (days)6.7±4.18.2±4.90.073
EuroSCORE – European System for Cardiac Operative Risk Evaluation; CVA – cardiovascular accident; COPD – chronic obstructive pulmonary disease; DM – diabetes mellitus; CAD – coronary artery disease; ACEI/ARB – angiotensin converting enzyme/angiotensin receptor blocker; GPS – Glasgow prognostic scale; POAF – post operative atrial fibrillation.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750